CPI Announces Global Partnership with Cambridge Design Partnership

Collaboration can benefit everyone, from the partners to the end users of the products and services they offer. In this manner, CPI and Cambridge Design Partnership announced a global partnership with the goal of maximizing potential of next-generation diagnostic and healthcare technologies, shaping the leading edge of innovation into commercial readiness and ensuring UK leadership in medical technologies that transform the healthcare experience.

Each partner bring their expertise to the collaboration. UK-based CPI is an independent deep-tech innovation center and founding member of the High Value Manufacturing Catapult. Cambridge Design Partnership delivers end-to-end product and technology development for clients in the healthcare, consumer, and industrial equipment sectors.

The partnership enriches the capabilities of both businesses. Cambridge Design Partnership gains access to CPI’s expertise and capabilities in development and business scale-up.
Projects at CPI benefit from its GMP and ISO13485 certified Quality Management System, ensuring compliance with relevant legislation and standards.

CPI secures access to Cambridge Design Partnership’s expertise, built over hundreds of client projects. This includes novel technologies such as molecular diagnostics, synthetic biology, and advanced therapies.

The success of the partnership will be measured in terms of commercial and patient impact. The two companies plan to shape early-stage innovation into investment ready business cases and market-ready products. This will streamline the development of effective products and technologies, providing value to patients within key clinical areas such as infectious disease and oncology.

“The UK has a strong science and technology base, with a history of scientific firsts behind many great products now on the global stage,” Pari Datta, Cambridge Design Partnership’s senior innovation consultant, said. “But we don’t always spot the opportunities or navigate the path to commercialization, particularly in the regulated medical space. With CPI, we’re working to grow the ecosystem which will discover, nurture and scale these promising businesses, leading to great new products delivering real value to patients, professionals and the UK economy.”

“Increasingly, we’re witnessing collaborative approaches to innovation development,” Arun Harish, director of strategy at CPI, added. “Collaboration is at the heart of CPI’s strategy as we continue to serve multiple established and emerging industries. We’re pleased to be partnering with CDP to develop and accelerate diagnostics and healthtech products, where the potential for innovation is immense.”